3-CHLORO-1-(OXAN-2-YL)-1H-PYRAZOLO[3,4-B]PYRIDINE, 95.0%, 1g

2-Amino-3-bromobenzamide, 95.0%, 5g

TERT-BUTYL 3-(6-METHOXYPYRIDIN-3-YL)PROPANOATE, 95%, 250mg

(E)-ETHYL 3-(THIOPHEN-3-YL)ACRYLATE, 95.0%, 250mg

5-Fluorobenzofuran, 95.0%, 1g

1-Phenylethanamine, 95.0%, 500ml

Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)praseodymium(III) [NMR Shift Reagent]>98.0%(T)1g

3,5-Dichlorobenzyl alcohol, 98.0%, 500g

(4R,4'R)-2,2'-(CYCLOPROPANE-1,1-DIYL)BIS(4-BENZYL-4,5-DIHYDROOXAZOLE), 95%, 100mg

(4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)DIHYDROFURAN-2(3H)-ONE, 95.0%, 5g

(5-Bromo-2-(trifluoromethyl)pyridin-4-yl)methanol, 95.0%, 250mg

5-tert-butyl 3-ethyl 7-methyl-2H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3,5-dicarboxylate, 98%, 500mg

4-[2-(4-Bromophenoxy)ethyl]morpholine, 97.0%, 100mg